CAS: 55676-22-7; 3-Acetyl-6-Chloropyridine

相似化合物

149281-42-5 23092-75-3 1256791-13-5

上下游产品

CAS号923034-23-5 Propanedioic ac... | CAS号58757-38-3 6-氯吡啶-3-羰酰氯 | CAS号108-59-8 丙二酸二甲酯 | CAS号53939-30-3 5-溴-2-氯吡啶 | CAS号78191-00-1 N-甲氧基-N-甲基乙酰胺 | CAS号70258-18-3 2-氯-5-氯甲基吡啶 | CAS号75-16-1 甲基溴化镁 | CAS号149281-42-5 6-氯-N-甲氧基-N-甲基烟酰胺 | CAS号33252-28-7 6-氯-3-氰基吡啶 | CAS号216317-64-5 3-(6-氯吡啶-3-基)-3... | CAS号19828-20-7 2-氨基-5-乙酰基吡啶 | CAS号173901-08-1 2-chloro-5-[(2R... | CAS号265107-43-5 1-[6-(吗啉-4-基)吡啶... | CAS号265107-41-3 Ethanone, 1-[6-... | CAS号265107-45-7 1-(6-(PYRROLIDI... | CAS号68700-92-5 2-chloro-5-prop... | CAS号810662-41-0 Ethanone, 1-[6-... | CAS号84331-01-1 1-(四唑并[1,5-a]吡啶... | CAS号93297-75-7 2-chloro-5-pyri...

Propanedioic Acid,2-[(6-Chloro-3-Pyridinyl)Carbonyl]-,1,3-Diethyl Ester 以 水,二甲基亚砜 作为反应溶剂,化学反应 3.0H,以94 G的收率获得产物2-氯-5-乙酰基吡啶
参考文献:高活性亚胺基苯乙酸酯类化合物及其制备方 法和应用
标题:高活性亚胺基苯乙酸酯类化合物及其制备方 法和应用
摘要:本发明属于农药领域,具体涉及高活性亚胺基苯乙酸酯类化合物及其制备方法和应用.本发明致力于新型甲氧基丙烯酸酯类化合物的研究,在结构上引入吡啶芳醚结构,拓宽了该类新化合物结构的研究,发现了高活性亚胺基苯乙酸酯类化合物.该类化合物表现出与嘧菌酯和肟菌酯相当的生物活性,对多数病原菌具有较好的效果,尤其对油菜菌核病菌防治效果突出,在低剂量下依然有效.

专利信息

专利号:US-9221821-B2
优先权日:2012-06-05
标题:Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds
发明人：DIEP NHUT; KALYAN YURIY B
权利人:FOREST LAB HOLDINGS LTD; FOREST LAB HOLDINGS LTD
摘要:Methods for the synthesis of disubstituted aminouracils and xanthine and/or xanthine-related compounds are provided.

专利号:US-8742118-B2
优先权日:2011-10-27
标题 :Methods for preparing intermediates of perampanel
发明人：FONTANA FRANCESCO; STABILE PAOLO
权利人:F I S —FABBRICA ITALIANA SINT S P A
摘要:Methods for the synthesis of 2-alkoxy-5-(pyridin-2-yl)pyridine of formula I n nor salts thereof are provided.

专利号:US-2023002426-A1
优先权日:2019-11-15
标题 :Chiral synthesis of a tertiary alcohol

专利号:WO-2021097139-A1
优先权日:2019-11-15
标 题 :Chiral synthesis of a tertiary alcohol

专利号:US-2019152962-A1
优先权日:2016-07-14
标题 :Cyclopropyl derivatives as ror-gamma modulators
发明人：DESAI RANJIT; KUMAR SANJAY S; PANDYA VRAJESH; DESAI JIGAR; RAVAL SAURIN
权利人:CADILA HEALTHCARE LTD
摘要:The present invention provides compounds which are modulators of RORγ and their use for the treatment of diseases or conditions mediated by RORγ. Further, the present invention relates to processes of preparing such compounds, their tautomeric forms, novel intermediates involved in their synthesis, their pharmaceutically acceptable salts, methods for using such compounds and pharmaceutical compositions containing them (Formula I).

专利号:CA-2693182-A1
优先权日:2007-06-29
标 题:Pyrimidine compounds, methods of synthesis thereof, and use thereof in the treatment of raf kinase-mediated disorders